FRRSF yields 33.06% · PFE yields 6.13%● Live data
📍 FRRSF pulled ahead of the other in Year 1
Combined, FRRSF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of FRRSF + PFE for your $10,000?
Foremost Lithium Resource & Technology Ltd., an exploration company, engages in the identification and development of mineral properties in Canada and the United States. It explores for lithium, silver, and gold properties. The company has 100% interests in the Zoro Lithium project that comprise three contiguous areas/claims with a total area of approximately 3,603 hectares located in Snow Lake, Manitoba; and the Winston property that includes 149 unpatented lode, the Ivanhoe and Emporio patented, and four unpatented mining claims located in Sierra County, New Mexico. It also holds an option agreement to acquire a 100% interest in the Jean Lake lithium-gold project that covers an area of 1002 hectares located to the north of Winnipeg, as well as 90% interests in the Hidden Lake project comprises five contiguous claims covering approximately 1,659.29 hectares located in the Northwest Territories. The company was formerly known as Far Resources Ltd. and changed its name to Foremost Lithium Resource & Technology Ltd. in January 4, 2022. Foremost Lithium Resource & Technology Ltd. was incorporated in 2005 and is headquartered in Vancouver, Canada.
Full FRRSF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.